Lundbeck continues to show solid revenue growth and strong

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
52
Lundbeck continues to show solid revenue growth and strong improvement in profitability

Valby, Denmark, 2017-02-08 07:42 CET (GLOBE NEWSWIRE) -- HIGHLIGHTS

  • Revenue reached DKK 15,634 million in 2016 representing an increase of 7% compared to last year
    • Revenue in the US reached DKK 8,404 million, up 32% (30% in local currency)
    • Revenue in International Markets reached DKK 3,993 million, up 4% (7% in local currencies)
    • Revenue in Europe reached DKK 2,912 million, down 25% (25% in local currencies)
  • Revenue from key products grew 79% (78% in local currencies) to DKK 6,541 million in 2016 representing 42% of total revenue
    • Abilify Maintena® reached DKK 1,114 million, up 67% (67% in local currencies)
    • Brintellix®/Trintellix® reached DKK 1,105 million, up 76% (79% in local currencies)
    • Northera® reached DKK 1,087 million, up 129% (128% in local currency)
    • Onfi® reached DKK 2,409 million, up 37% (34% in local currency)
    • Rexulti® reached DKK 826 million, up 608% (608% in local currency)  
  • EBIT improved significantly reaching DKK 2,292 million. In 2016, the EBIT margin reached 14.7% compared to a negative EBIT margin of 46.7% in 2015. In 2015, EBIT included an impairment loss and restructuring charges of close to DKK 7 billion, and 2016 included an impairment loss of DKK 140 million relating to idalopirdine
  • The free cash flow reached DKK 2,789 million compared to a cash outflow of DKK 2,645 million last year. The net position has changed from interest bearing debt of DKK 2.2 billion at the end of 2015 to a positive net cash position of DKK 326 million
  • For 2017, Lundbeck expects revenue of DKK 16.3-17.1 billion and EBIT of DKK 3.4-3.8 billion
  • The Board of Directors proposes to pay a dividend of DKK 2.45 per share, corresponding to a pay-out ratio of 40%. Lundbeck revises its dividend policy and increases the dividend pay-out ratio from the current 30%-40% of net profits to 60%-80% of net profits from 2017 and onwards

In connection with the financial report, Lundbeck’s President and CEO, Kåre Schultz said:

“I am pleased with our strong operational performance in 2016 where we have delivered results that exceeded our own expectations. I am confident that we can deliver on our targets for the coming years.”

DKK million FY2016  FY2015 Growth
Reported Revenue 15,634 14,594 7%
Reported EBIT 2,292 (6,816) -
Reported EPS 6.14 (28.96) -
Reported EBIT margin 14.7% (46.7%) -
       
Core Revenue* 15,634 14,464 8%
Core EBIT* 3,477 847 311%
Core EPS* 11.14 1.56 614%
Core EBIT margin* 22.2% 5.9% -

*For definition of the measures “Core Revenue” and “Core EBIT”, see note 3 Core reporting

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Update: Russell 2000 Surges Amid Tech and Crypto Movements

Updated Category News Views 190

Market Movement Overview On a bustling Tuesday morning, investors are turning their gazes towards the small-cap sector, with the Russell 2000 experiencing a notable rise of 1%. This outperformance signals a shift in market sentiment, as many anticipate a potential rate cut by the Federal Reserve. Such expectations have fueled confidence in smaller, economically sensitive...

Continue Reading
MEXC Introduces Innovative CORN Token and Exciting Rewards

Updated Category News Views 218

MEXC Launches Listing of CORN Token with Exciting Rewards MEXC, a prominent global cryptocurrency exchange, has made waves in the blockchain community by announcing the listing of CORN (CORN) on both spot and futures markets. This significant event coincides with a thrilling Airdrop+ rewards initiative, boasting a dazzling prize pool of 149,000 USDT. Understanding the...

Continue Reading
Revolutionizing Lawn Care: Meet ANTHBOT Genie Today!

Updated Category News Views 337

Revolutionizing Lawn Care with ANTHBOT Genie Homeowners around the world often find lawn care to be a never-ending task, consuming their weekends and requiring physical effort. Enter ANTHBOT, here to change all of that with their incredible creation, the ANTHBOT Genie. This AI-powered robotic mower promises to transform lawn maintenance into an effortless, fully automated...

Continue Reading
Thumzup Media Surpasses 800 Advertisers with Remarkable Growth

Updated Category News Views 251

Thumzup Media Corporation Achieves Key Milestone Thumzup Media Corporation, an emerging leader in social media branding and innovative marketing solutions, has reported a major milestone of surpassing 800 advertisers. This achievement represents a significant growth trajectory for the company amidst a thriving digital advertising landscape. Rapid Expansion in Advertising...

Continue Reading
Flagstar Bank's Strategic Workforce Changes Enhance Efficiency

Updated Category News Views 183

Flagstar Bank's Strategic Approach to Workforce Changes In a move aimed at enhancing efficiency and driving transformation, Flagstar Bank has announced significant workforce changes. These adjustments are a crucial part of the bank's comprehensive strategy to streamline operations and reduce costs, enabling better service delivery and overall performance. Understanding...

Continue Reading